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Abstract Primary headaches are often associated with
pain in the maxillofacial region commonly classified under
the term ‘‘orofacial pain’’ (OFP). In turn, long-lasting OFP
can trigger and perpetuate headache as an independent
entity, which is able to persist after the resolution of the
main disorder. A close association between OFP and
headache complicates their cause and effect definition and
leads to misdiagnosis. The precise mechanisms underlying
this phenomenon are poorly understood, partly because of
the deficiency of research-related findings. We combined
the animal models of OFP and headache—the orofacial
formalin test and the model of trigeminovascular noci-
ception—to investigate the neurophysiological mecha-
nisms underlying their comorbidity. In anesthetized rats,
the ongoing activity of single convergent neurons in the
spinal trigeminal nucleus was recorded in parallel to their
responses to the electrical stimulation of the dura mater
before and after the injection of formalin into their cutaneous
receptive fields. Subcutaneous formalin resulted not only in
the biphasic increase in the ongoing activity, but also in an
enhancement of neuronal responses to dural electrical
stimulation, which had similar time profile. These results
demonstrated that under tonic pain in the orofacial region a
nociceptive signaling from the dura mater to convergent
trigeminal neurons is significantly enhanced apparently
because of the development of central sensitization; this may
contribute to the comorbidity of OFP and headache.
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Introduction
Primary headaches, especially migraine and tension-type
headaches, are often associated with pain in the maxillo-
facial region commonly classified under the term ‘‘orofa-
cial pain’’ (OFP) [1, 2]. The latter usually accompanies the
temporomandibular joint disorders (TMD), masticatory
myofascial lesions as well as sinus-related and odontogenic
inflammation or tumor [3, 4].
Close relationship between OFP and headache compli-
cates their cause and effect definition and often serves as a
reason to classify these pain syndromes together [3].
Indeed, every primary headache, including cluster head-
ache and paroxysmal hemicrania, can occur in the maxil-
lofacial region atypical for them, i.e. felt as OFP, which
leads to misdiagnosis and, as a result, to inadequate treat-
ment [4–8]. Migraineurs often complain of a pain in the
face, temporomandibular joint noise, tension and tender-
ness of the masticatory muscles [9]. In addition, patients
with primary headaches are more likely than healthy peo-
ple to demonstrate dysfunctions in the jaw area, which are
commonly attributed to TMD [1, 10].
Contrariwise, the orofacial pathology can be accompa-
nied by typical headache that also complicates the diag-
nostic definition [11–13]. In this case, the headache per se
should be considered as a secondary pain, i.e. as a symptom
of the main disorder [14, 15]. However, long-lasting OFP
can trigger and perpetuate headache as an independent
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entity, which is able to persist after the primary disease
resolution [4]. In such an event, the comorbid state is
described, under which the exacerbating relationship
between OFP and headache occurs [3, 10, 13]. As reported,
more than half of patients seeking treatment for OFP
demonstrate symptoms of concomitant headache com-
monly classified as tension-type headache, chronic daily
headache or migraine [3, 16].
The relatively frequent comorbidity of OFP and head-
ache might be explained by the convergence of orofacial
and meningeal inputs in the spinal trigeminal nucleus
(STN), which is intimately involved in pathophysiology of
both pain syndromes [12, 17]. However, the precise
mechanisms underlying synergistic relationship between
OFP and headache are poorly understood, partly because of
the deficiency of research-related findings.
A valid and suitable animal model of persisting pain in
the orofacial region is the formalin test [18–20]. A typical
behavioral response to orofacial injection of formalin is
biphasic, with a short-lasting early phase and a prolonged
late one. In neurophysiological studies, the subcutaneous
injection of formalin into the orofacial receptive field of
innervating the whole craniofacial region convergent STN
neurons produced a prolonged biphasic increase in their
ongoing activity with a time course similar to that observed
in behavioral experiments [19, 21, 22].
The STN neurons are also known to play a prominent
role in pathophysiology of headaches by modulating pain
transmission from intracranial structures to higher centers
of the brain [23–25]. Therefore, the monitoring of STN
neuronal responses to electrical, mechanical or chemical
stimulation of the dura mater and meningeal vessels is
widely used in animal studies of headache [26–32].
In the present work in anesthetized rats, we combined
the animal models of OFP and headache (the orofacial
formalin test and the trigeminovascular nociception model)
to investigate neurophysiological mechanisms underlying
comorbidity of these disorders. Namely, we monitored the
ongoing activity of convergent neurons in the STN and
studied the changes in their responses to electrical stimu-
lation of the dura mater under formalin-induced inflam-
mation of face tissues.
Methods
All experiments were performed according to the Ethical
Guidelines of the International Association for the Study of
Pain. The study protocol and experimental design were
approved by the Institutional Animal Care and Use Com-
mittees of Saint Petersburg State Medical University and
Pavlov Institute of Physiology. Thirty adult male Wistar
rats (body weight 300–390 g) were used for the study. The
animals were housed 2–5 per cage and maintained on a
12-h light/dark schedule with free access to food and water.
Anesthesia and surgical preparation
Rats were anesthetized with urethane (800 mg/kg, i.p.; ICN
Biomedicals, Aurora, OH, USA) and a-chloralose (60 mg/
kg, i.p.; MP Biomedicals, Solon, OH, USA). Catheters were
placed into the femoral vein for administration of anesthetics
and myorelaxants, and into the femoral artery for continuous
monitoring of blood pressure. The trachea was intubated and
the head of the animal was fixed in a stereotaxic frame. The
neck muscles overlying the cisterna magna were separated
along the midline and C1 laminectomy was performed. The
dura mater was removed to expose the medulla and C1 spinal
cord. A longitudinal parietal craniotomy close to the superior
sagittal sinus was performed and the stimulating electrodes
were placed on the dura mater. The animal was paralysed
with pipecuronium bromide (i.v., 1.2 mg/kg initially,
maintenance 0.6 mg/kg as required; Gedeon Richter,
Budapest, Hungary) and artificially ventilated with room air
(75–100 cycles/min, 2–4 ml per cycle) using a small animal
ventilator. Rectal temperature was maintained between 37
and 38C by means of a servocontrolled heating pad. The
depth of anesthesia was assessed by monitoring blood
pressure responses to noxious stimulation; supplementary
anesthetic was administered when necessary to ensure the
absence of gross ([20% from the baseline level) blood
pressure fluctuations.
Electrical stimulation of the dura mater
Bipolar stimulating electrodes had resistance of 50 KX and
consisted of two varnish-insulated silver wires with beads
(0.3 mm in diameter) at the end. The electrodes were
placed on the dura mater in close proximity to the superior
sagittal sinus or visible blood vessels. The dura mater was
stimulated with single rectangular pulses of 25–50 V and
duration of 0.8 ms delivered by a computer-controlled
stimulator. The stimulus intensity was 1.5 times the
response threshold.
Extracellular recordings
Neuronal activity was recorded by varnish-insulated tung-
sten microelectrodes (Science Products, Hofheim, Ger-
many) with a tip diameter of 5 lm and resistance of 12 MX.
The electrodes were lowered into the STN at the level of C1
spinal cord in 4-lm steps using a microdrive unit. The
signals from the recording electrode were amplified and
passed to the analogue input of the computer A/D converter
by means of the multifunctional acquisition card. For on-
line acquisition, processing and displaying of data, the
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custom written software was used. To isolate the activity of
single units from adjacent cell potentials and noise, three-
level amplitude discrimination was used online. The ongo-
ing activity of trigeminal neurons and their responses to the
dural electrical stimulation were analyzed as peristimulus
time histograms, such that signals gated through the
amplitude discrimination were collected in successive bins
of 1 ms. For evoked responses, data were collected from 20
recordings (one per 3 s) over 50 ms after each electrical
stimulus. For histograms of ongoing activity pseudo stimu-
lation was used, that is, the same software as that for creating
histograms of evoked responses was used but electrical
stimulation was not actually applied. The histograms had a
sweep length of 500 ms and were created automatically
from 50 recordings (one per 1 s). All recorded units apart
from responses to the dural electrical stimulation were tested
for responses to mechanical stimulation of their dural and
facial cutaneous receptive fields by von Frey filaments
(North Coast Medical, Morgan Hill, CA, USA). Only neu-
rons demonstrating all three kinds of responses were selec-
ted for further testing.
Subcutaneous injection of formalin
Formalin solution was prepared at 5% in saline from a
formalin stock (an aqueous solution of 37% formaldehyde)
and injected subcutaneously into the center of the neuronal
facial mechanoreceptive field in a volume of 15 ll. The
onset of the injection was carried out 10 s after the first
instant of needle penetration. Formalin was administered in
20 rats. Other ten animals received subcutaneous injection
of isotonic saline and were used as control.
Experimental protocol
Neuronal activity was studied over 150 min after formalin
or saline administration. Recordings of ongoing and elec-
trically evoked neuronal activity with simultaneous crea-
tion of peristimulus time histograms were performed
before (0 min), and in 5, 10, 20, 30, 40, 50, 60, 75, 90, 105,
120, and 135 min after subcutaneous injection. In all
experiments, only one unit was tested in each animal. At
the end of the experiment, rats were killed by an overdose
of urethane ([3 g/kg, i.v.). The recording sites within the
spinal cord were marked by an electrolytic lesion through
the recording electrode. After routine histological pro-
cessing of the tissue, lesion sites were examined under a
light microscope.
Statistical analysis
Using peristimulus histograms, neuronal ongoing activity
and electrically evoked responses were expressed as a
mean number of spikes per second (spikes/s) or a mean
number of spikes per stimulus (spikes/stimulus), respec-
tively. Based on the results of the Shapiro–Wilk test of
normality, the nonparametric Friedman, Kruskal–Wallis,
Wilcoxon signed rank and Mann–Whitney–Wilcoxon tests
were used to determine the significance of changes in
neuronal activity following subcutaneous formalin or sal-
ine. Statistical significance was set at P \ 0.05. The data
are expressed as the mean value ± SEM. The analysis was
carried out using Origin 7.5 (OriginLab, Northampton,
MA, USA) and GraphPad InStat 3.02 (GraphPad Software,
La Jolla, CA, USA) software package.
Results
General properties of neurons
Extracellular recordings were made from 30 neurons
within the caudal part of the STN. The recorded neurons
were located in the region of the nucleus defined by a
rostrocaudal direction from 0.5 to 1.5 mm caudal to the
obex and mediolaterally from 2.0 to 2.5 mm left to the
middle line at the depth of 0.4–1.2 mm from the dorsal
surface of the spinal cord. All of them received convergent
afferent inputs from the dura mater and facial skin.
Recorded units showed a wide range of frequencies of
initial ongoing activity within an interval of 1–22 spikes/s
(Fig. 1). The mean rates of ongoing firing in the saline-
(N = 10) and formalin-treated (N = 20) groups did not
significantly differ (P = 0.48, U = 49.0, Mann–Whitney–
Wilcoxon test) at 7.3 ± 1.6 and 7.5 ± 1.6 spikes/s,
respectively.
Fig. 1 Representative native oscillographic recordings showing
changes in the ongoing activity of the spinal trigeminal neuron after
subcutaneous injection of formalin
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The neurons of both experimental groups showed an
excitatory response to electrical stimulation of the dura
mater with latencies mostly corresponding to the activation
of Ad-fibers (Fig. 2). At baseline, the mean rates of evoked
firing were not significantly different between the groups
(P = 0.82, U = 52.0, Mann–Whitney–Wilcoxon test). For
the saline-treated group, the value was 4.1 ± 0.3 spikes/
stimulus (N = 10), and for the formalin-treated group,
4.3 ± 0.4 spikes/stimulus (N = 20).
All recorded units had facial cutaneous receptive fields
and were classified as wide-dynamic range neurons. Their
mechanoreceptive fields were located in the periorbital
area, on the vibrissa pad, on the upper lip and on the
dorsum of the nose.
Effects of subcutaneous formalin on the ongoing
neuronal activity
The injection of saline into the cutaneous receptive field
(N = 10) did not cause substantial changes in the ongoing
neuronal activity. After the administration, the mean rate of
ongoing firing in this group was not significantly altered
(P = 0.14, Fr = 6.8, Friedman test) and at each time point
was comparable to its baseline level (7.3 ± 1.6 spikes/s,
P [ 0.05, Wilcoxon signed rank test).
In turn, subcutaneous injection of formalin produced a
pronounced increase in ongoing activity in 11 (55%) of
formalin-treated units. The Friedman test revealed the
maximal level of difference between formalin-induced and
baseline firing in this group (P \ 0.0001, Fr = 78.2,
Friedman test). The reaction as a rule consisted of two
phases. Five minutes after the administration, the neurons
showed an increase in the mean discharge rate up to
32.0 ± 6.0 spikes/s (N = 11; Fig. 1); this value was sig-
nificantly higher than the baseline level of ongoing activity
of these cells before formalin (7.7 ± 2.5 spikes/s, N = 11,
P = 0.003, Wilcoxon signed rank test) and exceeded
firing frequency of saline-treated cells at the same time
point (9.7 ± 1.9 spikes/s, N = 10, P = 0.0008, U = 12.0,
Mann–Whitney–Wilcoxon test; Fig. 3a). The brief first
phase of excitation was followed by a period of relatively
low ongoing activity. Twenty minutes after the injection, the
mean discharge rate was minimal at 16.5 ± 4.4 spikes/s
(N = 11); this level was comparable to that prior subcuta-
neous formalin (P = 0.06, Wilcoxon signed rank test;
Fig. 3a). The ensuing long-lasting second phase of increased
neuronal discharge began 30 min after the injection and
persisted until the end of the recording. By 40 min, the mean
firing rate of tested neurons increased to 24.7 ± 4.0 spikes/s
(N = 11); this value was significantly higher than the level
prior to formalin administration (P = 0.004, Wilcoxon
signed rank test) and exceeded the firing frequency of saline-
treated units (6.6 ± 1.4 spikes/s, N = 10, P \ 0.0001,
U = 4.0, Mann–Whitney–Wilcoxon test; Fig. 3a).
The ongoing activity continued to rise and by 90 min
reached its maximum at 42.5 ± 5.5 spikes/s (N = 11,
Fig. 2 Representative native oscillographic recording and corre-
sponding online produced histogram demonstrating the response of
the convergent spinal trigeminal neuron to electrical stimulation of
the dura mater. The arrow indicates the time of a single electrical
stimulus. The histogram is produced from 20 stimuli, bin = 1 ms
Fig. 3 The line plots demonstrating the effects of subcutaneous
injection of formalin on the ongoing activity of spinal trigeminal
neurons (a) and their responses to electrical stimulation of the dura mater
(b). Each line represents mean firing rates of neurons in different groups.
The data are shown as mean value ± SEM. Significant differences are
indicated as follows: #P \ 0.05, ##P \0.01, ###P \ 0.001 versus initial
level; *P \ 0.05, **P \ 0.01, ***P \ 0.001 versus saline-treated
group
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Figs. 1, 3a). The discharge rate then slightly declined and
135 min after the formalin injection was 35.0 ± 6.2 spikes/s
(N = 11); this value still significantly exceeded the base-
line level (P = 0.0002, Wilcoxon signed rank test) and was
higher than the firing level of the saline-treated cells at the
same time point (6.1 ± 1.7 spikes/s, N = 10, P = 0.0001,
U = 7.0, Mann–Whitney–Wilcoxon test). In total, within
50–135 min after the administration the Dunn’s rank sum
post hoc analysis for the Friedman test revealed the max-
imal level of difference between formalin-induced and
baseline firing of tested neurons (P \ 0.001). Between-
group comparison showed that the increase in ongoing
activity of cells activated by formalin at each point of
recording within the same time interval was significant
compared to the saline-treated ones (P \ 0.001, Mann–
Whitney–Wilcoxon test; Fig. 3a).
Meanwhile, nine (45%) neurons of the formalin-treated
group were unresponsive to the injection of formalin into
their cutaneous receptive fields and did not demonstrate
any noticeable changes in the ongoing activity. The mean
rate of ongoing firing was not significantly altered in this
group (P = 0.19, Fr = 16.1, Friedman test); at each time
point after the administration it was comparable to the
baseline level (7.3 ± 2.1 spikes/s, N = 9, P [ 0.05, Wil-
coxon signed rank test) and did not differ from the dis-
charge rate of the saline-treated cells (P [ 0.05, Mann–
Whitney–Wilcoxon test; Fig. 3a).
Thus, based on the effects of subcutaneous formalin in
the ongoing activity, we distinguished two groups of spinal
trigeminal neurons—those activating after the injection and
unresponsive neurons.
Effects of subcutaneous formalin on the responses
to electrical stimulation of the dura
A group of neurons demonstrating an increase in ongoing
activity after subcutaneous formalin (N = 11) showed also
significantly enhanced responses to electrical stimulation
of the dura mater (P \ 0.0001, Fr = 54.0, Friedman test).
The changes in evoked firing had time profile similar to
that observed in ongoing activity. Thus 5 min after the
administration, the neurons showed an increase in the mean
discharge rate up to 5.6 ± 0.8 spikes/stimulus (N = 11,
Figs. 3b, 4). However, this value did not significantly differ
from the baseline level (4.3 ± 0.6 spikes/stimulus,
N = 11, P = 0.28, Wilcoxon signed rank test) and was
comparable to electrically induced response of saline-
treated cells at the same time point (4.8 ± 0.5 spikes/
stimulus, N = 10, P = 0.45, U = 21.0, Mann–Whitney–
Wilcoxon test; Fig. 3b). Within the next 5 min, evoked
neuronal activity slightly decreased to 5.3 ± 0.7 spikes/
stimulus.
Twenty minutes after the formalin administration, the
electrically induced firing of tested neurons gradually
enhanced and by 40 min, it significantly increased to
7.0 ± 1.0 spikes/stimulus (N = 11, P = 0.02, Wilcoxon
signed rank test). After 90 min, the mean discharge rate
was 9.6 ± 1.3 spikes/stimulus (N = 11); this value maxi-
mally exceeded the baseline level (P = 0.0006, Wilcoxon
signed rank test; Figs. 3b, 4). Within the period of
105–135 min, the evoked activity fell to 8.2 ± 1.1 spikes/
stimulus (N = 11); this level was still significantly higher
than that prior to formalin administration (P = 0.004,
Wilcoxon signed rank test). According to the Dunn’s rank
sum post hoc analysis for Friedman test, the most signifi-
cant increase (P \ 0.001) in electrically induced neuronal
activity compared to its baseline level was revealed
between 75 and 120 min after subcutaneous formalin. In
turn, the difference between evoked firing of formalin- and
saline-treated cells became significant 30 min after the
injection (P = 0.02, U = 8.0, Mann–Whitney–Wilcoxon
test), was maximal at 90 min (P = 0.0003, U = 0.0) and
slightly declined at the end of recording (P = 0.006,
U = 3.5; Fig. 3b).
Fig. 4 Representative off-line processed histograms showing
changes in the response of the spinal trigeminal neuron to dural
electrical stimulation after subcutaneous injection of formalin. In each
case, the arrow indicates the time of a single electrical stimulus. The
stimulus artifact is suppressed by the amplitude discrimination. The
histograms are produced from 20 stimuli each, bin = 1 ms
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In contrast, the group of neurons with formalin-unre-
sponsive ongoing activity (N = 9) did not show any
noticeable changes in their responses to the electrical
stimulation of the dura mater (P = 0.19, Fr = 15.9,
Friedman test). The mean rate of evoked firing of these
units at each time point after formalin administration did
not differ from the baseline level (4.2 ± 0.5 spikes/stim-
ulus, N = 9, P [ 0.05, Wilcoxon signed rank test) and was
comparable to the discharge rate of the saline-treated cells
(P [ 0.05, Mann–Whitney–Wilcoxon test; Fig. 3b).
Thus, trigeminal neurons demonstrating biphasic
increase in ongoing activity after subcutaneous formalin
were also characterized by the enhancement of responses to
electrical stimulation of the dura mater with similar time
profile.
Discussion
This is the first study to demonstrate that subcutaneous
injection of formalin into the orofacial receptive field of the
STN neurons results not only in biphasic increase in their
ongoing activity, but also in an equal enhancement of
neuronal responses to electrical stimulation of the dura
mater, which has similar time profile. A group of trigem-
inal neurons, unresponsive to subcutaneous formalin, was
also revealed and it did not demonstrate any changes in
their ongoing activity or in evoked firing.
The orofacial formalin test is a widely accepted model
of tonic pain in the corresponding region, which allows for
the study of both behavioral and neurophysiological
aspects of this pain condition [18–22]. On the other hand,
because the dura mater and major brain vessels innervated
by thin unmyelinated trigeminal afferents are known to be
the main sources of pain in cephalalgias [23–25], electrical
stimulation of the dura is considered to be a valid
method of activating the trigeminovascular system and
mimicking nociceptive processes occurring during head-
ache [26, 29–32].
Combining the orofacial formalin test and the electrical
model of trigeminovascular nociception, we demonstrated
that under persisting OFP the nociceptive signaling to STN
from the dura mater was significantly facilitated, although
the dural afferents were unaffected by experimental
inflammation and therefore they were not the primary
source of pain. The enhancement of STN neurons respon-
ses to electrical stimulation of the dura together with the
increase in their ongoing activity indicated that these two
processes were inextricably associated. However, unlike
changes in the ongoing activity, the significant increase in
neuronal responses to the dural stimulation occurred only
in the second phase of the formalin test, whereas their
alterations in the first phase were comparable to those
observed in the saline-treated group. This needs further
explanation.
As revealed previously, the expression of the second
phase of the formalin test depends primarily on nociceptive
signaling from the periphery, i.e. from the tissue affected
by formalin-induced inflammation [33, 34]. The central
neuroplasticity, if it occurs, seems to play a secondary and
therefore less prominent role in the process. In turn, the
long-term repetitive electrical stimulation of the dura mater
does not produce significant changes in the evoked activity
of the STN neurons [35] and it also does not result in their
wind-up [36]. Meanwhile, it has been recently shown that
in the state of hyperexcitation induced by inflammatory
challenge of the dura mater, the spinal trigeminal neurons
together with the increase in ongoing activity and reduction
of thresholds to mechanical stimulation of the facial
receptive field demonstrated significant enhancement of
responses to the dural electrical stimulation [30, 31]; this
allowed us to consider the latter as an additional marker of
central sensitization.
Taking into account everything mentioned above, we
suppose that the increase in responses of the STN cells to
dural electrical stimulation, observed in the second phase
of the orofacial formalin test, can be a result of changes in
neuronal excitation, i.e. manifest the development of cen-
tral sensitization. It is reasonable to suggest that this pro-
cess is a direct consequence of tonic nociceptive signaling
from the peripheral site of formalin-induced inflammation.
As evidenced by similar time-courses of changes in
ongoing and electrically induced neuronal activities, a
persistent nociceptive flow from the periphery not only
initiates the sensitization of central trigeminal neurons, but
also maintains it. However, the enhanced responsiveness of
the STN neurons in the second phase of the formalin test
also seemed to contain an autonomous component, inde-
pendent of peripheral input. This assumption can be sup-
ported by the following considerations.
Firstly, after subcutaneous injection of formalin, the
STN neurons recorded in the present study demonstrated
the facilitation of responses to electrical stimulation of the
chemically intact dura mater, which progressed in the
course of the experiment. Undoubtedly, it is usually diffi-
cult to differentiate between the enhanced excitation of the
STN neurons per se and the increased afferent input from
the periphery. Indeed, the escalation of ongoing activity,
observed in the second phase of the formalin test, can be
explained by continuous signaling from the inflammation
site. However, taking into account that dural afferents,
unlike cutaneous ones, were unaffected by formalin, it is
reasonable to suppose that the increase in neuronal
responses to the dural electrical stimulation demonstrated
within the same time interval was ingenuously conditioned
by alterations in the functional state of the STN cells. The
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significant changes in electrically induced activity occurred
only 30 min after subcutaneous injection of formalin, i.e.
within the time period, minimally sufficient for the
induction of central sensitization [27]. The obtained data
are consistent with the results of other experiments on
sensitization of spinal trigeminal neurons induced by the
topical application of inflammatory soup (IS) on the dura
mater [27, 28]. In these experiments, the decrease in
thresholds of the STN neurons to the mechanical stimula-
tion of the dura mater, as a result of the local activation of
dural nociceptors by IS and subsequent peripheral sensiti-
zation, was accompanied by increased sensitivity and
expansion of chemically intact neuronal cutaneous recep-
tive fields, which are considered to be an obvious sign of
central sensitization.
Secondly, in the present study, the hyperactivity of the
STN neurons was observed even 2 h after the onset of the
second phase of the formalin test indicating the persistence
of this state that is typical for the phenomenon of central
sensitization [27]. It should be noted here that the com-
pletion of each experiment was not caused by the attenu-
ation of neuronal activity, but was limited by the
experimental design. At the same time, the duration of
behavioral response in the second phase of the orofacial
formalin test does not exceed 30–35 min, which indicates
the termination of formalin action and the attenuation of
pain signaling from the periphery by that time [18, 22].
As it is known, the STN neurons are characterized by the
reception of convergent somatovisceral afferent inputs
from both extra- and intracranial tissues. This peculiarity
determines the location and irradiation of pain in various
OFP and headache and underlies their comorbidity [2, 12,
37, 38]. Our study demonstrates that persisting pain in the
orofacial region can promote a significant facilitation of
nociceptive transmission from craniovascular structures to
the CNS apparently because of the sensitization of the STN
convergent neurons, whose activation is considered to be an
important component of headache neurobiology. It is gen-
erally assumed that a persistent increase in the excitation
of these neurons determines the typical clinical manifes-
tations of primary headaches, for example, the occurrence
of cutaneous allodynia, and forms the basis of the mecha-
nisms leading to the development of chronic conditions
[27, 28, 39]. We suppose that the data obtained in the
present study can contribute to understanding of neuro-
physiological processes underlying the comorbidity of OFP
and headache.
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